Anwar, S.; Tan, W.; Hong, C.-C.; Admane, S.; Dozier, A.; Siedlecki, F.; Whitworth, A.; DiRaddo, A.M.; DePaolo, D.; Jacob, S.M.;
et al. Quality-of-Life (QOL) during Screening for Phase 1 Trial Studies in Patients with Advanced Solid Tumors and Its Impact on Risk for Serious Adverse Events. Cancers 2017, 9, 73.
https://doi.org/10.3390/cancers9070073
AMA Style
Anwar S, Tan W, Hong C-C, Admane S, Dozier A, Siedlecki F, Whitworth A, DiRaddo AM, DePaolo D, Jacob SM,
et al. Quality-of-Life (QOL) during Screening for Phase 1 Trial Studies in Patients with Advanced Solid Tumors and Its Impact on Risk for Serious Adverse Events. Cancers. 2017; 9(7):73.
https://doi.org/10.3390/cancers9070073
Chicago/Turabian Style
Anwar, Sidra, Wei Tan, Chi-Chen Hong, Sonal Admane, Askia Dozier, Francine Siedlecki, Amy Whitworth, Ann Marie DiRaddo, Dawn DePaolo, Sandra M. Jacob,
and et al. 2017. "Quality-of-Life (QOL) during Screening for Phase 1 Trial Studies in Patients with Advanced Solid Tumors and Its Impact on Risk for Serious Adverse Events" Cancers 9, no. 7: 73.
https://doi.org/10.3390/cancers9070073
APA Style
Anwar, S., Tan, W., Hong, C. -C., Admane, S., Dozier, A., Siedlecki, F., Whitworth, A., DiRaddo, A. M., DePaolo, D., Jacob, S. M., Ma, W. W., Miller, A., Adjei, A. A., & Dy, G. K.
(2017). Quality-of-Life (QOL) during Screening for Phase 1 Trial Studies in Patients with Advanced Solid Tumors and Its Impact on Risk for Serious Adverse Events. Cancers, 9(7), 73.
https://doi.org/10.3390/cancers9070073